CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: CCK8 assay, colony-forming assay and flow cytometry (FCM) were used to evaluate the effect of the ZFNs on the viablity and apoptosis of CML cells and CML CD34+ cells.